Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy-Reference-Cited by-同舟云学术

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

Published:1997-06 Issue:9069 Volume:349 Page:1857-1863
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Publisher

Elsevier BV

Subject

General Medicine

Reference36 articles.

1. Dietary protein intake and the progressive nature of kidney disease: the role of haemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis;Brenner;N Engl J Med,1982

2. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation;Hostetter;Am J Physiol,1981

3. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass;Anderson;J Clin Invest,1985

4. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat;Anderson;J Clin Invest,1986

5. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy;Mogensen;BMJ,1982

Cited by 1357 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The evidence base of the 10 most prescribed drugs in England, France, and the United States: a scoping review;Journal of Clinical Epidemiology;2024-10

2. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension;European Heart Journal;2024-08-30

3. Effect of blood pressure control on the risk of proteinuria during bevacizumab treatment in patients with colorectal cancer: a single-center retrospective cohort study;Journal of Pharmaceutical Health Care and Sciences;2024-08-23

4. The Broader Effects of Delayed Progression to End-Stage Kidney Disease: Delaying the Inevitable or a Meaningful Change?;Advances in Therapy;2024-08-14

5. Treatment of arterial hypertension in patients with chronic kidney disease from the perspective of the 2023 European recommendations;Kazan medical journal;2024-07-25